Search fresh public links, source activity, and ready-to-use post angles for Ipr.
Fresh curated links around IPR are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
IPR petition filings have collapsed to historic lows in 2026 — the market's rational response to Director Squires' near-zero institution rate. Continue reading this post on Patentl...
A new inter partes review, IPR2026-00400, was filed on June 22, 2026, at the Patent Trial and Appeal Board against Thorne Research, Inc. The proceeding is one to watch for companie...
A new inter partes review, IPR2026-00400, was filed on June 22, 2026, at the Patent Trial and Appeal Board against Thorne Research, Inc. The proceeding is one to watch for companie...
U.S. Patent and Trademark Office Director John Squires granted three petitions for inter partes review in his newest bulk order and broke down why he previously rejected CyberSecur...
A new inter partes review, IPR2026-00387, was filed at the Patent Trial and Appeal Board on June 5, 2026, under the caption Optiver US LLC. At this early stage, the proceeding is n...
A new inter partes review, IPR2026-00387, was filed at the Patent Trial and Appeal Board on June 5, 2026, under the caption Optiver US LLC. At this early stage, the proceeding is n...
A U.S. Patent and Trademark Office decision denying a request for ex parte reexamination of a patent because it reused arguments from an inter partes review that was discretionaril...
On Thursday, May 14, U.S. Patent and Trademark Office (USPTO) Director John Squires issued a Director Discretionary Decision in which he denied institution of an inter partes revie...
The U.S. Patent and Trademark Office's new ex parte reexamination procedure, allowing patent owners to file preorder papers to inform the EPR decision process, marks the first mean...
Westinghouse Air Brake Technologies Corp.'s attempt to rely on other parties' claim constructions doomed its challenges to Railware Inc. railway traffic control patents, according...
The U.S. Patent and Trademark Office (USPTO) on late Monday issued a notice designating as precedential a Sua Sponte Director Review Order of a Patent Trial and Appeal Board (PTAB)...
Google’s petition for the U.S. Supreme Court to scrutinize the Patent Trial and Appeal Board's so-called settled expectations practice underscores why accused infringers facing old...
The U.S. Supreme Court today denied a petition for certiorari in Dolby Laboratories Licensing Corporation v. Unified Patents LLC, a case that asked the High Court to consider wheth...
Originally posted 2012-11-22 19:51:47. Republished by Blog Post PromoterThat’s the  Innovative Design Protection and Piracy Prevention Act, back up for another shot at the big lea...
The U.S. Patent and Trademark Office (USPTO) today held its third PTAB Listening Session, this one focused on Patent Trial and Appeal Board (PTAB) Administration and Reform. Paneli...
Another new inter partes review to watch at the Patent Trial and Appeal Board: IPR2026-00387, filed June 5, 2026, and captioned Optiver US LLC. At this early stage, the docket sign...
ResMed Corp. has been named in a new inter partes review, IPR2026-00341, filed on June 12, 2026, before the Patent Trial and Appeal Board. While the newly filed docket entry identi...
Another new inter partes review to watch at the Patent Trial and Appeal Board: IPR2026-00387, filed June 5, 2026, and captioned Optiver US LLC. At this early stage, the docket sign...
Though U.S. Patent and Trademark Office Director John Squires has drawn criticism for failing to explain his reasoning in inter partes review decisions, his recent precedential ord...
A new inter partes review filed at the Patent Trial and Appeal Board could be one to watch for companies operating at the intersection of life sciences, nutraceuticals, and consume...
A new post-grant review at the Patent Trial and Appeal Board is worth watching for practitioners tracking early-life patent challenges and the evolving use of PTAB proceedings agai...
The Patent Trial and Appeal Board will no longer conduct an inter partes review into the validity of an Omni MedSci wearable device patent, now that there will be a separate post-g...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.